Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
Selling, General & Administrative
Sonoma Pharmaceuticals Inc
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Selling, General & Administrative
-$7.3m
|
CAGR 3-Years
14%
|
CAGR 5-Years
18%
|
CAGR 10-Years
5%
|
|
Johnson & Johnson
NYSE:JNJ
|
Selling, General & Administrative
-$20.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
1%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Selling, General & Administrative
-$7.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-5%
|
|
Pfizer Inc
NYSE:PFE
|
Selling, General & Administrative
-$14.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
0%
|
|
Merck & Co Inc
NYSE:MRK
|
Selling, General & Administrative
-$10.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
1%
|
|
Eli Lilly and Co
NYSE:LLY
|
Selling, General & Administrative
-$7.4B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
0%
|
See Also
What is Sonoma Pharmaceuticals Inc's Selling, General & Administrative?
Selling, General & Administrative
-7.3m
USD
Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Selling, General & Administrative amounts to -7.3m USD.
What is Sonoma Pharmaceuticals Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
5%
Over the last year, the Selling, General & Administrative growth was 28%. The average annual Selling, General & Administrative growth rates for Sonoma Pharmaceuticals Inc have been 14% over the past three years , 18% over the past five years , and 5% over the past ten years .